Invention Grant
- Patent Title: Everninomicin biosynthetic genes
- Patent Title (中): Everninomicin生物合成基因
-
Application No.: US11739945Application Date: 2007-04-25
-
Publication No.: US07790411B2Publication Date: 2010-09-07
- Inventor: Thomas J. Hosted , Tim X. Wang , Ann C. Horan
- Applicant: Thomas J. Hosted , Tim X. Wang , Ann C. Horan
- Applicant Address: US NJ Kenilworth
- Assignee: Schering Corporation
- Current Assignee: Schering Corporation
- Current Assignee Address: US NJ Kenilworth
- Main IPC: C12P21/06
- IPC: C12P21/06 ; C12P19/34 ; C12N15/00 ; C12N1/20 ; C12N15/07 ; C07H21/02 ; C07H21/04

Abstract:
This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin everninomicin and to use of the nucleic acids and proteins to produce compounds exhibiting antibiotic activity based on the everninomycin structure. The DNA sequence for the gene clusters responsible for encoding everninomicin biosynthetic genes, which provide the machinery for producing everninomicin, are provided. Thus, this invention provides the nucleic acid sequences needed to synthesize novel everninomicin-related compounds based on everninomicin, arising from modifications of the DNA sequence designed to change glycosyl and modified orsellinic acid groups contained in everninomicin. A Micromonospora site-specific integrase gene is also provided, which can be incorporated in a vector for integration into any actinomycete, and, particularly into Monospora. Thus, the invention further provides methods for introducing heterologous genes into an actinomycete chromosome using this particular vector.
Public/Granted literature
- US20090004649A1 EVERNINOMICIN BIOSYNTHETIC GENES Public/Granted day:2009-01-01
Information query